Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BMS-488043 is a novel and unique oral small molecule HIV fusion inhibitor that inhibits the attachment of Human Immunodeficiency Virus type 1 (HIV-1) to CD4(+) lymphocytes.BMS-488043 is used for the treatment of immune disorders, infections, and genitourinary disorders, and can be used in the study of HIV infect
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 32,000 | |||
5 mg | 在庫あり | ¥ 78,000 | |||
10 mg | 在庫あり | ¥ 117,000 | |||
25 mg | 在庫あり | ¥ 190,000 | |||
50 mg | 在庫あり | ¥ 264,000 | |||
100 mg | 在庫あり | ¥ 356,000 | |||
500 mg | 在庫あり | ¥ 682,000 |
説明 | BMS-488043 is a novel and unique oral small molecule HIV fusion inhibitor that inhibits the attachment of Human Immunodeficiency Virus type 1 (HIV-1) to CD4(+) lymphocytes.BMS-488043 is used for the treatment of immune disorders, infections, and genitourinary disorders, and can be used in the study of HIV infect |
別名 | CHEMBL238103, UNII-MKS21EJ435, BMS 043, BMS488043, BMS 488043 |
分子量 | 422.43 |
分子式 | C22H22N4O5 |
CAS No. | 452296-83-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (118.36 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BMS-488043 452296-83-2 Microbiology/Virology Proteases/Proteasome HIV Protease CHEMBL 238103 UNII-MKS21EJ-435 CHEMBL238103 UNII-MKS21EJ435 BMS 043 UNII-MKS21EJ 435 CHEMBL-238103 BMS043 BMS488043 BMS-043 BMS 488043 Inhibitor inhibitor inhibit